| protein
| phosphorylated p65 associating with CREBBP and displaying the HDAC1-p50 complex |
|
kappa light chain enhancer |
|
governing the expression of genes encoding cytokines, chemokines, growth factors, cell adhesion molecules, acute phase proteins |
|
interacting with TNIP1 (effects of TNIP1 on NFKB1 processing and of NFKB1 on stabilizing TNIP1 act to potentiate the NF-kappaB inhibitory activity of TNIP1)  |
|
NFKB1 activation by CSF2RB is dependent on TNFR-associated factor 6 (TRAF6) and association of TRAF6 with CSF2RB requires a consensus-binding motif found in other molecules known to interact with TRAF6 |
|
NFKB1 regulates the expression of UACA, a novel apoptosis regulator, with involvement of proteasome and caspase for its degradation |
|
critical role for NFKB1 in USP6-mediated tumorigenesis, suggesting that NFKB1 inhibitors may function as effective therapeutic agents in the treatment of aneurysmal bone cyst (ABC) |
|
IL15 can signal via IL15RA, JNK, and NFKB1 to drive CCL5 production by myeloid cells |
|
SCGB1A1 gene transfer may inhibit airway inflammation through suppressing the activation of NFKB1, which may provide us a new consideration in the therapy of airway inflammation |
|
NLRC3 inhibited TLR-dependent activation of the transcription factor NFKB1 by interacting with the TLR signaling adaptor TRAF6 to attenuate Lys63 (K63)-linked ubiquitination of TRAF6 and activation of NFKB1 |
|
molecular link between two essential determinants of the circadian and immune mechanisms, the transcription factors CLOCK and NFKB1, respectively |
|
GNB2 is required for starvation-induced NFKB1 activation and constitutive NFKB1 activity |
|
FGFR2 serves as a scaffold for multiple components of the NFKB1 signaling complex |
|
TBK1 negatively regulated IgA class switching by attenuating noncanonical signaling via the transcription factor NFKB1, an action that involved TBK1-mediated phosphorylation |
|
its activity regulates mesenchymal stem cell accumulation at tumors, by inducing VCAM1 and thereby its interaction with tumor vessel endothelial cells |
|
NFKB1 mediates TNFSF13-induced HOXC4 transcription |
|
NFKB1 exerts an inhibitory effect on the ability of HES6 to promote cortical neuronal differentiation |
|
PLK4 is a direct NFKB1 target gene |
|
NFKB1 inhibits NOD2-induced cytokine secretion through ATF3-dependent mechanisms |
|
ZAP70 acts directly as an amplifier of NFKB1 signalling in Chronic lymphocytic leukaemia (CLL) cells which could be an underlying mechanism for its association with poor prognosis and which may represent a therapeutic target |
|
KLF6 is an essential co-activator of NFKB1, suggesting new insight into the molecular regulation of RELA-dependent gene expression |
|
IKBKB activates two "master" transcription factors of the innate immune system, IRF5 and NFKB1 |
|
ECSIT specifically interacted with RELA/NFKB1 proteins, which colocalized in the nucleus |
|
NFKB1 may be involved in IL1B-induced activation of ADAMTS9 in human chondrocytes |
|
CCL18 enhances hepatocellular carcinoma cell migration, invasion, and EMT through the expression of PITPNM3 and the activation of the NFKB1 signaling pathway |
|
NFKB1 is a critical positive regulator, whereas YY1 is a negative regulator of the TGFA promoter |
|
TRAF7 is involved in signal transduction pathways that lead either to activation or repression of NFKB1 transcription factor |
|
|
